These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 23721146

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.
    Fatterpekar GM, Galheigo D, Narayana A, Johnson G, Knopp E.
    AJR Am J Roentgenol; 2012 Jan; 198(1):19-26. PubMed ID: 22194475
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis.
    Larsen VA, Simonsen HJ, Law I, Larsson HB, Hansen AE.
    Neuroradiology; 2013 Feb; 55(3):361-9. PubMed ID: 23262559
    [Abstract] [Full Text] [Related]

  • 5. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N, Dávila J, Medrano J, Olmos S.
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?
    Forsyth PA, Kelly PJ, Cascino TL, Scheithauer BW, Shaw EG, Dinapoli RP, Atkinson EJ.
    J Neurosurg; 1995 Mar; 82(3):436-44. PubMed ID: 7861222
    [Abstract] [Full Text] [Related]

  • 8. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
    Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, Zarudzki L.
    Folia Neuropathol; 2010 Mar; 48(2):81-92. PubMed ID: 20602289
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study.
    Dequesada IM, Quisling RG, Yachnis A, Friedman WA.
    Neurosurgery; 2008 Nov; 63(5):898-903; discussion 904. PubMed ID: 19005380
    [Abstract] [Full Text] [Related]

  • 11. Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
    Shapiro LQ, Beal K, Goenka A, Karimi S, Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE, Gutin PH.
    Int J Radiat Oncol Biol Phys; 2013 Mar 01; 85(3):636-42. PubMed ID: 22765876
    [Abstract] [Full Text] [Related]

  • 12. Progress in neuro-oncology: imaging in-phase!
    Cottier JP.
    Diagn Interv Imaging; 2014 Oct 01; 95(10):905. PubMed ID: 25288181
    [No Abstract] [Full Text] [Related]

  • 13. [Brain MR perfusion and MR spectroscopy in differentiation of radiation necrosis from tumor recurrence (case report)].
    Tekşam M, Kayahan EM, Yerli H, Ağildere AM.
    Tani Girisim Radyol; 2004 Dec 01; 10(4):263-7. PubMed ID: 15611913
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
    Alexiou GA, Zikou A, Tsiouris S, Goussia A, Kosta P, Papadopoulos A, Voulgaris S, Tsekeris P, Kyritsis AP, Fotopoulos AD, Argyropoulou MI.
    Magn Reson Imaging; 2014 Sep 01; 32(7):854-9. PubMed ID: 24848292
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
    Chaichana KL, McGirt MJ, Niranjan A, Olivi A, Burger PC, Quinones-Hinojosa A.
    Neurol Res; 2009 Nov 01; 31(9):931-9. PubMed ID: 19215664
    [Abstract] [Full Text] [Related]

  • 17. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N, Morales H, Modrego PJ, Pina MA.
    Acad Radiol; 2006 Jun 01; 13(6):728-37. PubMed ID: 16679275
    [Abstract] [Full Text] [Related]

  • 18. Application value of apparent diffusion coefficient in differentiation of brain radiation-injuries and glioma recurrence.
    Wang YL, Liu MY, Li JF, Zhang J, Sun L, Feng F, Ma L.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug 01; 34(4):396-400. PubMed ID: 22954125
    [Abstract] [Full Text] [Related]

  • 19. Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence.
    Kim HS, Kim JH, Kim SH, Cho KG, Kim SY.
    Radiology; 2010 Sep 01; 256(3):906-15. PubMed ID: 20634429
    [Abstract] [Full Text] [Related]

  • 20. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS, Li CF, Liu H, Zhen JH, Feng DC.
    Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):151-8. PubMed ID: 17289287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.